NYSE: RCUSArcus Biosciences Inc Earnings Dates, Reports, Calls
Arcus Biosciences earnings were -$391.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest RCUS earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$112.0M, up 19.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RCUS reported annual earnings of -$283.0M, with -7.8% growth.
RCUS earnings history
Current Revenue
$141.0M
Current Earnings
-$391.0M
Current Profit Margin
-277.3%
RCUS Return on Equity
Current Company
-70.6%
Current Industry
-60.2%
Current Market
31.5%
RCUS's Return on Equity (-70.6%)... subscribe to Premium to read more.
High Return on Equity Performance
RCUS undefined
Current Company
-33%
Current Industry
-2.5%
RCUS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when RCUS announces earnings.
RCUS undefined
Current Company
-40.04%
Current Industry
5.8%
RCUS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
RCUS vs Biotech Stocks
Arcus Biosciences Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.